Skip to main content

Jacob S Sherkow

Professor

Additional Campus Affiliations

Professor, College of Law
Affiliate, Carl R. Woese Institute for Genomic Biology
Professor, Biomedical and Translational Sciences
Director, IP Law Program, College of Law

Recent Publications

Sherkow, J. S., Park, J. K., & Lu, C. Y. (2024). Regulating Direct-to-Consumer Polygenic Risk Scores. Obstetrical and Gynecological Survey, 79(2), 81-83. https://doi.org/10.1097/01.ogx.0001008520.24751.6b

Sherkow, J. S., Cook-Deegan, R., & Greely, H. T. (2024). The Myriad Decision at 10. Annual Review of Genomics and Human Genetics, 25(1), 397-419. https://doi.org/10.1146/annurev-genom-010323-011239

Lemley, M. A., & Sherkow, J. S. (2023). The Antibody Patent Paradox. Yale Law Journal, 132(4), 994-1064. https://doi.org/10.2139/ssrn.4032912

Sachs, R., Ouellette, L. L., Price II, W. N., & Sherkow, J. S. (2023). Innovation Law and Covid-19: Promoting Incentives and Access for New Health Care Technologies. In I. G. Cohen, A. R. Gluck, K. L. Kraschel, & C. Shachar (Eds.), Covid-19 and the Law: Disruption, Impact and Legacy (pp. 225-236). Cambridge University Press. https://doi.org/10.1017/9781009265690.025

Sherkow, J. S., Adashi, E. Y., & Cohen, I. G. (2023). Assessing—and Extending—California’s Insulin Manufacturing Initiative. JAMA - Journal of the American Medical Association, 329(7), 533-534. https://doi.org/10.1001/jama.2023.0013

View all publications on Illinois Experts